Pancreatic Cancer Drug Combo Shows 92% Response Rate, Advances to Phase 3
Reported by Reuters
Sentiment
Positive
Importance
9
Price
$28.675
Mkt Cap
$2.925B
52W Low
$3.12
52W High
$28.41
Market data snapshot near publication time
Summary
Tango Therapeutics announced a 92% objective response rate for its vopimetostat and daraxonrasib combination therapy in pancreatic cancer, with no new safety signals. This exceptionally strong clinical data for a difficult-to-treat cancer significantly de-risks the program. The company plans to advance the combination into Phase 3, marking a major step towards potential commercialization and a transformative event for the company.
At the time of this announcement, TNGX was trading at $28.67 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2.9B. The 52-week trading range was $3.12 to $28.41. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: Reuters.
Price Chart
TNGX - Latest Insights
TNGX
Jun 08, 2026, 7:15 AM EDT
Price at Filing:
$32.09
Real-time Price:
$29.53
Change:
-$2.56 (-8%)
Market Cap:
$2.925B
TNGX
Jun 08, 2026, 7:01 AM EDT
Price at Filing:
$28.67
Real-time Price:
$29.53
Change:
+$0.8555 (+3%)
Market Cap:
$2.925B
TNGX
May 13, 2026, 4:23 PM EDT
Price at Filing:
$23.49
Real-time Price:
$29.53
Change:
+$6.04 (+26%)
Market Cap:
$2.925B
TNGX
May 13, 2026, 4:16 PM EDT
Tango Therapeutics Reports Q1 Results, Extends Cash Runway to 2028, and Announces Board Resignations
Price at Filing:
$23.49
Real-time Price:
$29.53
Change:
+$6.04 (+26%)
Market Cap:
$2.925B
TNGX
May 13, 2026, 4:15 PM EDT
Price at Filing:
$23.49
Real-time Price:
$29.53
Change:
+$6.04 (+26%)
Market Cap:
$2.925B
TNGX
May 08, 2026, 9:22 AM EDT
Price at Filing:
$23.40
Real-time Price:
$29.53
Change:
+$6.13 (+26%)
Market Cap:
$2.925B
TNGX
Apr 15, 2026, 9:19 AM EDT
Tango Therapeutics Appoints New CFO and Principal Accounting Officer to Drive Late-Stage Development
Price at Filing:
$24.45
Real-time Price:
$29.53
Change:
+$5.08 (+21%)
Market Cap:
$2.925B
TNGX
Mar 05, 2026, 7:15 AM EST
Price at Filing:
$12.31
Real-time Price:
$29.53
Change:
+$17.22 (+140%)
Market Cap:
$2.925B
TNGX
Mar 05, 2026, 7:11 AM EST
Price at Filing:
$12.00
Real-time Price:
$29.53
Change:
+$17.53 (+146%)
Market Cap:
$2.925B
TNGX
Mar 05, 2026, 7:10 AM EST
Price at Filing:
$12.31
Real-time Price:
$29.53
Change:
+$17.22 (+140%)
Market Cap:
$2.925B